Karen Prange, Director at AtriCure, Inc. (ATRC), sold 713 shares at $47.89 ($34K) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Open-market sale of $34k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2025-03-07 | $465K | — | Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| VRAY | BUY | 2022-05-12 | $100K | — | Filing → |